MedPath

Comparison of effects of BD Micro Fine Plus and NANOPASS Needle II in diabetic patients with insulin therapy

Not Applicable
Conditions
Diabetes
Registration Number
JPRN-UMIN000023673
Lead Sponsor
Kansai Rosai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have trouble determining the pain intensity, or any other criterion associated with the questionnaire.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of puncture site pain using the visual analogue scale
Secondary Outcome Measures
NameTimeMethod
HbA1c, Adverse events (dribbling, bleeding, needle breakage)
© Copyright 2025. All Rights Reserved by MedPath